Long-term experience of residual symptoms following treatment for localized prostate cancer: An Australian sample

Asia-Pacific Journal of Clinical Oncology

Volumn 3, Issue 4, 2007, Pages 199-206

  Wootten, Addie C ^a   Burney, Sue ^a   Frydenberg, Mark ^b   Foroudi, Farshad ^c   Ng, Kim T ^a   Coleman, Grahame ^a  

^a MONASH UNIVERSITY   (Australia)

^b MONASH MEDICAL CENTRE   (Australia)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Long term outcomes; Prostate cancer; Quality of life; Residual symptoms

Indexed keywords

HORMONE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AUSTRALIA; CANCER HORMONE THERAPY; CANCER SURVIVAL; CONTROLLED STUDY; COPING BEHAVIOR; ERECTILE DYSFUNCTION; EXTERNAL BEAM RADIOTHERAPY; HEALTH SURVEY; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MALE SEXUAL DYSFUNCTION; MINIMAL RESIDUAL DISEASE; PATIENT ATTITUDE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; RATING SCALE; RESIDUAL URINE; SCORING SYSTEM; URINE INCONTINENCE;

EID: 36749086527     PISSN: 17437555     EISSN: 17437563     Source Type: Journal    
DOI: 10.1111/j.1743-7563.2007.00134.x     Document Type: Article

References (20)

1. Cooperberg MR, Broering JM, Litwin MS et al. The contemporary management of prostate cancer in the United States: Lessons from the Cancer of the Prostate Strategic Urologic Research Endeavour (CaPSURE) a national disease registry. J Urol 2004; 171: 1393-401.
2. Christie D, Denham J, Steigler A et al. Delayed rectal and urinary symptomatology in patients treated for prostate cancer by radiotherapy with or without short term neo-adjuvant androgen deprivation. Radiother Oncol 2005; 77 (2): 117-25.
3. Denham J, Steigler A, Lamb D et al. Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: Results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial. Lancet Oncol 2005; 6 (11): 841-50.
4. Jo Y, Junichi H, Tomohiro F, Yoshinari I, Masato F. Radical prostatectomy versus high-dose rate brachytherapy for prostate cancer. Effects on health-related quality of life. Br J Urol Int 2005; 96: 43-7.
5. Lubeck DP, Litwin MS, Henning JM, Stoddard ML, Flanders SC, Carroll PR. Changes in the health related quality of life in the first year after treatment for prostate cancer: Results from CaPSURE. Urology 1999; 53: 180-6.
6. Nguyen LN, Pollack A, Zagars GK. Late effects after radiotherapy for prostate cancer in a randomised dose-response study: Results of a self-assessment questionnaire. Urology 1998; 51: 991-7.
7. Schwartz K, Bunner S, Bearer R, Severson RK. Complications from treatment for prostate carcinoma among men in the Detroit area. Cancer 2002; 95: 82-9.
8. Van Andel G, Visser AP, Zwinderman AH, Hulshof MCCM, Horenblas S, Kurth KH. A prospective longitudinal study comparing the impact of external beam radiation therapy with radical prostatectomy on health related quality of life (HRQOL) in prostate cancer patients. Prostate 2004; 58: 354-65.
9. Korfage IJ, Essink-Bot M, Borsboom GJJM et al. Five-year follow-up of health-related quality of life after primary treatment of localised prostate cancer. Int J Cancer 2005; 116: 291-6.
10. von Hippel PT. Biases in SPSS 12.0 missing value analysis. Am Stat 2004; 58: 160-4.
11. Tabachnick BG, Fidell LS. Using Multivariate Statistics, 4th edn. Allyn and Bacon, Needham Heights, CA 2001.
12. Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Brook RH. The UCLA prostate cancer index: Development, reliability, and validity of a health-related quality of life measure. Med Care 1998; 36: 1002-12.
13. Holden CA, McLachlan RI, Pitts M et al. Men in Australia telephone survey (MATeS): A national survey of the reproductive health and concerns of middle-aged and older. Aust Men Lancet 2005; 366: 218-24.
14. Reis F, Netto NR, Reinato JAS, Theil M, Zani E. The impact of prostatectomy and brachytherapy in patients with localised prostate cancer. Int Urol Nephrol 2004; 36: 187-90.
15. Lepor H, Kaci L, Xue X. Continence following radical retropubic prostatectomy using self-reporting instruments. J Urol 2004; 171: 1212-15.
16. Wei JT, Dunn RL, Marcovich R, Montie JE, Sanda MG. Prospective assessment of patient reported urinary continence after radical prostatectomy. J Urol 2000; 164: 744-8.
17. Krupski TL, Saigal CS, Litwin MS. Variation in continence and potency by definition. J Urol 2003; 170: 1291-4.
18. Wei JT, Montie JE. Comparison of patients' and physicians' rating of urinary incontinence following radical prostatectomy. Semin Urol Oncol 2000; 18: 76-80.
19. Potosky AL, Davis WW, Hoffman RM et al. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: The prostate cancer outcomes study. J Natl Cancer Inst 2004; 96: 1358-67.
20. Schover LR, Fouladi RT, Warneke CL et al. Defining sexual outcomes after treatment for localized prostate carcinoma. Cancer 2002; 95: 1773-85.